Brief: Orgenesis Received Nasdaq Hearings Panel Decision Which Granted Company Until October 14 To Regain Compliance With Bid Price And Equity Rules
11/06/2024 22:29
Orgenesis Inc ORGS.O :
* ORGENESIS : RECEIVED NASDAQ HEARINGS PANEL DECISION WHICH
GRANTED COMPANY UNTIL OCTOBER 14 TO REGAIN COMPLIANCE WITH BID
PRICE AND EQUITY RULES
Source text for Eikon: ID:n0001493152-24-023471
Further company coverage: ORGS.O
Recent news on Orgenesis
See all newsBrief: Orgenesis Nasdaq To Delist Co'S Common Stock, Securities Trading Will Be Suspended On Oct 21
Brief: Orgenesis Announces Positive Results From A Real-World Study Of Org-101 Car-T Therapy
Brief: Orgenesis Announces Strategic Partnership With Harley Street Healthcare Group
Brief: Orgenesis Says Entered Purchase Deal With Theracell For Purchase Of 50% Outstanding Ownership Rights & Equity Interests In Theracell Laboratories Ike
Brief: Orgenesis Received Nasdaq Hearings Panel Decision Which Granted Company Until October 14 To Regain Compliance With Bid Price And Equity Rules